Cerevel Therapeutics Holdings, Inc. Net Income 2021-2024 | CERE
Cerevel Therapeutics Holdings, Inc. net income from 2021 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Cerevel Therapeutics Holdings, Inc. Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $-433 |
| 2022 | $-352 |
| 2021 | $-225 |
| 2020 | $-148 |
| 2019 | $-128 |
| 2018 | $-116 |
| Cerevel Therapeutics Holdings, Inc. Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-03-31 | $-132 |
| 2023-12-31 | $-133 |
| 2023-09-30 | $-96 |
| 2023-06-30 | $-100 |
| 2023-03-31 | $-104 |
| 2022-12-31 | $-93 |
| 2022-09-30 | $-100 |
| 2022-06-30 | $-90 |
| 2022-03-31 | $-68 |
| 2021-12-31 | $-59 |
| 2021-09-30 | $-62 |
| 2021-06-30 | $-53 |
| 2021-03-31 | $-51 |
| 2020-12-31 | $-29 |
| 2020-09-30 | $-39 |
| 2020-06-30 | $-27 |
| 2020-03-31 | $-53 |
